CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ZURA — Zura Bio Ltd

CIK 884546 SAN FRANCISCO, CA

Position in ZURA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,028,930

+$843,909 QoQ

Shares Held

174,395

+460.8% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 95 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ZURA ranks #225 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,028,930	174,395	+460.8%	Shares	Sole	2026-08-14
2026-03-31	$185,021	31,096	-81.6%	Shares	Sole	2026-05-15
2025-06-30	$177,639	169,180	-41.4%	Shares	Sole	2025-08-12
2025-03-31	$372,295	288,601	-2.6%	Shares	Sole	2025-09-15
2024-12-31	$740,402	296,161	+1.5%	Shares	Sole	2025-02-06
2024-09-30	$1,184,736	291,807	+51.3%	Shares	Sole	2024-11-12
2024-06-30	$674,922	192,835	+5.2%	Shares	Sole	2024-08-12
2024-03-31	$470,931	183,242	+2.4%	Shares	Sole	2024-05-09
2023-12-31	$835,986	179,012	+86.3%	Shares	Sole	2024-02-06
2023-09-30	$634,240	96,097	+31.8%	Shares	Sole	2023-11-08
2023-06-30	$597,985	72,925	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.